DBIBB is a non-lipid agonist of specific lysophosphatidic acid (LPA2) type 2 G-protein-coupled receptor. It is a potentially active molecule for the treatment of acute radiation syndrome caused by high intensity gamma rays on hematopoietic and gastrointestinal systems. It is an intermediate in organic synthesis and drug research. DBIBB can be used to prepare various compounds that reduce gastrointestinal radiation syndrome, increase intestinal crypt survival and intestinal cell proliferation, and reduce cell apoptosis.
Molecular Weight:
452.48
Purity:
99.10%
CAS Number:
[1569309-92-7]
Formula:
C23H20N2O6S
Target:
LPA Receptor|||Apoptosis
T22070
* VAT and and shipping costs not included. Errors and price changes excepted
